Standard BioTools

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

BIIB

BPMC

CRML

ITCI

RADX

SAGE

SIBN

Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday

penny stock tips 3

Long Ideas

Penny Stocks

Insider Trades

MRDB

SYPR

Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying

Penny,Stock,Investments,Taking,Off,Concept

Pre-Market Outlook

PAPL

Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying

Standard BioTools Inc

Direxion Daily S&P Biotech Bear 3X Shares

LABORATORIOS FARMACEUTICO by LABORATORIOS FARMACEUTICOS ROVI SA

Laboratorios Farmaceuticos Rovi SA

Landos Biopharma Inc COM NEW

LABS Group

Direxion Daily S&P Biotech Bull 3X Shares

METASPHERE LABS INC by METASPHERE LABS INC.

Metasphere Labs Inc

Press Releases

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

Earnings

Standard BioTools Reports Third Quarter 2024 Financial Results

Standard BioTools to Participate in Upcoming Investor Conferences

Management

Standard BioTools Appoints Alex Kim as Chief Financial Officer

Health Care

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

General

Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Standard BioTools

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga